RxDoctor Payments Data

Jacob Larsen, PA

Physician Assistant · Twin Falls, IDNPI 1558730291

Payments from drug & device makers

$658in general payments, 2019–2025

Across 23 payments — averaging $28.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$173
  • AbbVie$136
  • Novartis$97
  • Teva Pharmaceuticals USA, Inc.$73
  • Bristol Myers Squibb$32
  • UCB, Inc.$24
  • plus $123 from 6 others

What the payments were for

  • Food & beverage$58589%
  • Education$7311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$658 in reported general payments places this provider in the 65th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$9,989
Medicare patients
85
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide17$20,042
FarxigaDapagliflozin Propanediol15$12,174
EliquisApixaban12$7,913
Incruse ElliptaUmeclidinium Bromide11$3,720
Estradiol12$1,704
Atorvastatin Calcium54$901
Gabapentin38$579
Albuterol Sulfate HfaAlbuterol Sulfate12$410
Levothyroxine Sodium53$408
Omeprazole26$401
Lisinopril46$340
Pregabalin13$291
Quetiapine Fumarate17$287
Pantoprazole Sodium30$284
Oxycodone Hcl11$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$18$12,17415 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$18$40853 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Twin Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →